Shareholders Equity and Capital Stock (Details 7) |
6 Months Ended |
---|---|
Jun. 30, 2023
USD ($)
$ / shares
shares
| |
Warrants | |
Exercise price | $ / shares | $ 1.46 |
Number of warrants | shares | 55,830,530 |
Remaining contractual life (years) | 2 years |
Aggregate Intrinsic Value | $ | $ 0 |
Exercise price $1.35 | |
Exercise price | $ / shares | $ 1.35 |
Number of warrants | shares | 16,730,530 |
Remaining contractual life (years) | 7 months 6 days |
Aggregate Intrinsic Value | $ | $ 0 |
Expiry | Feb. 04, 2024 |
Exercise price $1.50 | |
Exercise price | $ / shares | $ 1.50 |
Number of warrants | shares | 39,100,000 |
Remaining contractual life (years) | 2 years 7 months 6 days |
Aggregate Intrinsic Value | $ | $ 0 |
Expiry | Feb. 21, 2026 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|